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Using llow cytometry and Auorescencc polarization illlill~SiS. spcallb I I ‘r- Turnmy! p:ptide-binding sims wcreshown to be Ioca:ed inside T-lymphocy~cs, 
macrophagcs and neuroblastoma cells. but not inside B-cells. No binding sites were found on the ccl1 surracc. The number oT binding sites Tar cxh 
cell type was dctermincd. Two types of binding sites wcrc observed Ibr myclomonocytic WEHI- cells with I%‘~ values of 21 and 540 nM. Inhibition 
analysis demonstrated that ror elleetive binding. an intact glycopcptidc molcculc and D-conOguration of isoglulaminc rcsiduc arc important. 
Muramyl pcptidc-binding site; Mammalian cell: Flow cytotnctry 
1. INTRODUCTION 
Structural components of the bacterial cell wall - 
muramic acid-containing glycopeptides (MPs) - 
produce multiple biological effects on the immune and 
central nervous systems of mammals [ 1,2]. They demon- 
strate adjuvant activity, cause growth inhibi!ion and 
necrosis of certain tumours, and induce non-specific 
resistance to bacterial and viral infections. 
Despite of a large number of studies dealing with 
murampl peptides, the molecular mechanism of their 
activity remains unclear. Different conclusions were 
reached concerning the presence of MP-binding mole- 
cules on target cells [3-51. Only recently the presence of 
these molecules was demonstrated for macrophages and 
B-cells, though their location (on the plasma membrane 
or inside the cells) is still under discussion [6,7]. 
In the present study, by means of flow cgtometry and 
fluorescence polarization analysis, the presence and lo- 
cation ~1’ specific MP-binding sites for cells of various 
!ineages were investigated. 
2. MATERIALS AND METHODS 
Macrophagcs were isolated from peritoneal cells or Bulb/r mice by 
adhcrcncc IO plastic Petri dishes as in [8]. Normal B-and T-cells were 
isolated from spleens or C57BL16 mice. Macrophagcs were depleted 
by adhcrcncc to plastic. Cell lines wcrc maintained in RPM1 1640 
rlb6reritrfiurts: MP, muramyl peptidc; GMDP, GlcNAc-@I-4-Mur- 
NAc-alanyl-D-isoglutamine; L-GMDP. GlcNAc-Dl-4-MurNAc-ala- 
nyl-isoglutaminc; GMDP-Lys, GlcNAc-PI-4-MurNAc-alanyl-D-iso- 
gluramyl-lysinc; PBS, phosphate-buffered saline. 
Corrcs/torr~/~~ttre rr /h.ss: V.A. Ncsmcyanov. Shcmyakin Inslilulc of 
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medium supplamcntcd with IO% fetal calFserum. 2 mM glutamincttnd 
0.05 mhl 3.mcrcaptocth;tnoI. 
Diseccharidc-containing muramyl peptidcs (DMP) used in this 
study were synthesized as dcscribcd earlier 191. FITC was conjugated 
to GXIDP-L-lysinc (GhlDP-Lys) as in [IOj. Resulting lluorcsccinthio- 
carbamoyl-Lys-GMDP(GMDP-Lys-FluTC) was isolated by rcvcrse- 
phase HPLC on a Zorb;ts ODS column (0.4 x 24 cm, DuPont. USA) 
using an acctonitrilc gntdient (O-60%) in 0.05 M ammonium ac%ttC 
bulTcr, pH 60. 
Cells (5 x IO’ per ml) wcrc fixed Tar IO min with 4% paraformaldc- 
hydc in PBS. pH 7.4. aad p:rmcabilizcd by treating with 02%B_octyl 
glucosidc in PBS for 5-10 min. 
GMDP-Lys-FluTC (IOJ@ and various doses of inhibitors ranging 
rrom 0.01 to IOOjrg wcrcaddcd siniultancously to 5x 10s pcrmcabiliz- 
cd cells in 100 ~1 PBS containing 1% bovine sc’rum albumin (PUS- 
BSA). Incubation was carried out Tar 30 min al 4°C in 111~ dark. Vhtblc 
cells wcrc trentcd simikuly in an ice bath with GMDP-Lys-FluTC in 
PBS-BSA containingO.Ot% sodium azidc. Alicr incubation. cells were 
washed twice with PBS-BSA and once with PBS. 
Double immunotluorwxn staining or spleen cells (5 x IO’) with 
__ _-^. 
bivtut*-Lys-FiuTC ulld phycorryiiirin-iabciied nlonocional dliii- 
L3T4 antibody (Bccktoa-Dickinson, USA) or rhodamin-labcllcd anti- 
mouse Ig antibodies (DAK0 Parls. Denmark) Wits carried out I‘or 30 
min at 4°C in PBS-BSA-sodium azidc. 
Flow cytomctcr EPICS ‘Elite’ (Coultcr, USA) WIS used. The daIa 
wcrc evaiuatcd using the Multigrdph program (Coultcr. USA). 
2.5. Fl~rotwwtrre polrrri:~;riorr rtt rtlysis 
GMDP-Lys-FluTC (IOpg) and various doses of inhibitors rtmging 
liom 0.01 IO IOOpg wcrc nddcd IO 7.5 x IO’ pcrmcabilizcd cells hi I .5 
ml PBS. 
Fluorcsccncc polarization was mctasurcd on Hitachi-MPF4 spcctro- 
lluorimctcr (I-liwhi, JiIpaIl) in quartz cells (IO x IO mm) at 37’C by 
IIIC standard proccdurc[l I] taking into account the light sctttcring of 
the cell suspension (cxcitilti0n wavclcngth, 490 inn; emission wave- 
Icngth, 515 nm). 
The Traction or bound ligand and K,, values wcrc dctcrmincd accord- 
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Fig. I. Fluorcsccm ligand (GMDP-Lys-FluTC) used in lhc study. 
in& 10 Lnkowitcz [I?]. Dissocialion cons~;m~s wcrc culcula~cd from a 
Scatchard plol [ 131. 
3. RESULTS AND DISCVSSIOX 
Among possible molecular mechanisms of biological 
activity of Ml%., the receptor mechanism seems to be the 
most probable [14,15], a!though conflicting data has 
been published on this subject [3-71. In order to clarify 
this question, a fluorescein-labclled derivative of 
GMDP-Lys was synthesized with a fluorcsceinthiocar- 
bomoyl residue attached to the E-amino group of lysine 
(Fig. I). This derivative had immunostimulatory activ- 
ity comparable to GMDP and GMDP-Lys, causing la 
antigen induction on murine peritoneal macrophages. 
Binding of GMDP-Lys-FluTC to normal cells and 
cell lines was studied by using 2 methods, namely flow 
cytometry and fluorescence polarization analysis. Both 
approaches gave identical results. No specific binding 
sites were found on the ceil plasma membrane. In con- 
trast, a large number of MP-binding sites was found 
inside all cells studied, although specific binding could 
be demonstrated for only murine macrophages and 
myelomonocytic cells (WEHI-3j, human ncuroblas- 
toma cells (IMR-?2), human (Jurkat) and rat (LSK) -. . . , 
1 -cells, out not for ilii.iiYilC m,,.., ,,... ,__ _. *r~lnn~a (CP3/0, P.A_lj and 
lymphoma (EL-4) cells (Table I). 
The presence of spccilic DMP-binding sites for T-, 
but not for B-cells was confirmed by using two-colour 
flow cytometric analysis of permeabilized macrophagc- 
depleted murine spleen cells (see Fig. 2j, stained with 
either phycoerythrin-labelled anti-L3T4 (T-helper mar- 
ker) antibody or rhodamin-labclled anti-lg antibodies 
(B-cell marker) plus GblDP-Lys-FluTC. For both phy- 
coerythrin- and rhodamin-labclled cells, binding of 
GMDP-Lys-FluTC was observed, but only for phyco- 
erythrin-labelled cells could this binding bc inhibited by 
GMDP (Fig. 2C). 
Our results obtained for murine peritoneal macro- 
phagcs agree with the data obtained by Tcnu et al. [7] 
GWDP-l.ysWuTC GMDP-L/S-FI-SC 
Fig. 2. Flo~v cylomctric analysis or GMDP-Lys-FluTC binding IO 
murinc spleen T- and B-cells. A.B: in ~hc abscncc. C.D: in the prcscncc 
of uniabelicd G?viDP. 
for rat alveolar macrophages. In contrast Silverman et 
al. [6] have found MP-binding sites on the plasma mem- 
brane of murine macrophages. Our data do not exclude 
the presence of a low number of MP-binding sites on the 
cell surface, because the fluorescent label used in this 
study enables the detection of not less thiin iO3 binchg 
sites per cell. Consequently, the several hundred specific 
T;lblc I 
Number of MP-binding sites ror various cells and cell lines cslimalcd 
by flow cylomclry 
Cells Number of binding h&’ 
Pcrmcabilizcd cells 
TOM Spccilic 
Viable cells 
TowI Spccilic 
Mncrophagcs 
WEHI- 
JURKAT 
EL-4 
LSK 
PAI 
sp2io 
IMR-32 
I50000 98000 (65%) eooo 
88000 30350 (35%) 4300 
I79900 40700 (23%) 9700 
I35300 none <1000 
I32500 32800 (‘5%) 2700 
49700 none eooo 
35900 now eooo 
593200 75000 (13%) eooo 
*Avcrirgc number OUI ol’al IC;ISI 3 cxpcrimcnls 
<IO00 
<IO00 
Cl000 
<IO00 
<IO00 
<IO00 
<IO00 
<IO00 
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Fig. 3. Fluorescence polarization analysis of binding oTGMDP-Lys- 
FluTC to ‘&‘EHl-3 cells. I~rser, Scatchard plot of the data. 
MP-binding sites per cell as observed by Silverman et 
al. [6] could remain undetected. 
Fluoresce nce polarization data for WEHl-3 cells re- 
vealed the ;~esence of 2 types of DMP-binding sites 
with Kd values of 21 and 540 nM (Fig. 3). The affinity 
of ligand binding is much lower than described [6] for 
resident macrophages (48 PM). Again we cannot ex- 
clude the presence of a low number of similar receptors 
on WEHI- cells, because the sensitivity of the method 
used was not high enough for their detection. 
Inhibition analysis showed that an intact GMDP 
structure as well as the stereochemistry of the molecule 
are essential for effective binding; the disaccharide Glc- 
NAc-MurNkc, tripeptide Ala-D-iGIn-Lys and the 
GMDP stereoisomer with a D-lgln residue substituted 
for the L-iGln (L-GMDP) were much less efficient in- 
hibitors than GMDP or GMDP-Lys (Fig. 4). Taking 
into account that these compounds are biologically in- 
active, the above data show a correlation between 
ligand specificity of binding and ligand specificity for 
bio!ogical activity. 
Thus, the MP-binding sites are located inside ma- 
crophages, T-helper cells and nerve cells. Evidently the 
ability of these cells to respond to MP depends on theit 
ability of uptake of the glycopeptide. This process is 
easiest for phagocytic cells, e.g. macrophages. Our re- 
su!ts corre!ate with functional studies showing that for 
activation of macrophages, MPs have to get inside the 
cell [!6,17]. 
InhibItOr 
/---+GMDP 
-_.-. ., 
0.0 1 
Concent%on 
Fig. 4. Inhibition oTGhlDP-Lys-FluTC binding to murinc perhoncal 
macrophages (circles) and WEHI- cells (triangles) by GXIDP. L- 
GMDP and tripeptidc Ala-D-iGIn-Lys. Inhibition is represcotcd as 
percent oTGMDF-Lys.FluTC-stained cells which changed their fluor- 
escence in the presence of inhibitor. 
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